EW News
Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?
Intuitive Surgical SP platform is gaining momentum as procedures, utilization and placements rise, with expanding indications and global adoption fueling growth.
Zacks
Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?
Intuitive Surgical SP platform is gaining momentum as procedures, utilization and placements rise, with expanding indications and global adoption fueling growth.
Zacks
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended Sept. 30, 2026 after the market closes on Wednesday, Nov. 4, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or...
Business Wire
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
Edwards Lifesciences (NYSE: EW) today announced that it will host an investor event in conjunction with the TCT annual scientific symposium in San Diego on Monday, Nov. 2, from 5:00 to 6:00 PM Pacific Time. The meeting will include a live Q&A session with physicians and members of the Edwards...
Business Wire
Edwards Wins FDA Approval For First Pediatric Surgical Pulmonary Valve
(RTTNews) - Thursday, Edwards Lifesciences (EW) announced that the U.S. FDA approved the AUTUS Size-Adjustable Valve, the first surgical pulmonary valve designed specifically for pediatric patients with congenital heart disease...
Nasdaq News: Markets
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
Edwards Lifesciences (NYSE: EW) today announced that the U.S. Food and Drug Administration (FDA) has approved the AUTUS Size-Adjustable Valve, a surgical pulmonary valve designed specifically for pediatric patients with congenital heart disease who require pulmonary valve replacement. For many...
Business Wire
$100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 7.57% on an annualized basis producing an average annual return of 16.73%. Currently, Edwards Lifesciences has a market capitalizationread more...
Benzinga
Edwards Lifesciences Comments on TAVR National Coverage Decision
Edwards Lifesciences (NYSE: EW) today issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare & Medicaid Services (CMS):Edwards is pleased that this updated policy represents an...
Business Wire
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders? Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, Sept. 7, 2026 Shareholders are encouraged to contact the firm to discuss their rights and...
PR Newswire
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
Edwards Lifesciences Corporation (NYSE: EW) will participate in the Deutsche Bank Healthcare Summit on Wednesday, Sept. 16, 2026.Bernard Zovighian, chief executive officer, is scheduled to present at 10:00 a.m. ET. Doretta Mistras, chief financial officer, will also participate in the conference. A...
Business Wire